Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01057381 · ClinicalTrials.gov registry record · Phase 4

Dexmedetomidine in Pediatric Tonsillectomy

A Phase 4 study of Post Operative Analgesia and Pediatric Adenotonsillectomy, sponsored by Baylor College of Medicine.

Completed
Registry status
Phase 4
Development phase
109
Enrollment target
1
Study location

NCT01057381: Completed Phase 4 study of Post Operative Analgesia and Pediatric Adenotonsillectomy, sponsored by Baylor College of Medicine.

NCT01057381 is a Phase 4 study of Post Operative Analgesia and Pediatric Adenotonsillectomy that has completed, run by Baylor College of Medicine. The registered enrollment target is 109 participants, roughly in line with the 108-participant average among 5 other Post Operative Analgesia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01057381, a Phase 4 study of Post Operative Analgesia and Pediatric Adenotonsillectomy, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
Phase 4
Development phase
109 participants
Enrollment target
1
Study location

Study Summary

The hypothesis of this study is that the administration of an intra-operative dose of dexmedetomidine will result in adequate analgesia without respiratory depression thereby resulting in an early discharge from the post anesthetic care unit following adenotonsillectomy.

Interventions

  • DRUG Dexmedetomidine 0.75 mcg/kg
  • DRUG Morphine 50 mcg/kg
  • DRUG Morphine 100 mcg/kg
  • DRUG Dexmedetomidine 1 mcg/kg

Study Locations (1)

Texas

  • Texas Children's Hospital, Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2005-08
Est. Completion 2010-12
Phase Phase 4
Baylor College of Medicine

616 total trials

What the finished NCT01057381 record still lists

NCT01057381 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 108-participant average among 5 other Post Operative Analgesia trials with a reported enrollment target.

The record links to 2 conditions, with Post Operative Analgesia appearing as the primary indexed condition, and to 4 interventions - of which Dexmedetomidine 0.75 mcg/kg is the first listed.

NCT01057381 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01057381 about?

NCT01057381 is a clinical study titled "Dexmedetomidine in Pediatric Tonsillectomy". The hypothesis of this study is that the administration of an intra-operative dose of dexmedetomidine will result in adequate analgesia without respiratory depression thereby resulting in an early discharge from the post anesthetic care unit following adenotonsillectomy.

What is the current status of trial NCT01057381?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 109 participants. The study started on 2005-08. Estimated completion is 2010-12.

What conditions does trial NCT01057381 study?

This clinical trial studies the following conditions: Post Operative Analgesia, Pediatric Adenotonsillectomy.

What interventions are being tested in trial NCT01057381?

The interventions under investigation include: Dexmedetomidine 0.75 mcg/kg (DRUG), Morphine 50 mcg/kg (DRUG), Morphine 100 mcg/kg (DRUG), Dexmedetomidine 1 mcg/kg (DRUG).

Who is sponsoring clinical trial NCT01057381?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01057381 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Operative Analgesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02421380 · 109 participants · NA

    Characterization of Hyperpolarized Pyruvate MRI Reproducibility

  • NCT04526600 · 109 participants · NA

    Fidgeting and Attentional and Emotional Regulation in ADHD

  • NCT04835584 · 109 participants · Phase 1

    KRT-232 and TKI Study in Chronic Myeloid Leukemia

  • NCT06626516 · 109 participants · Phase 1

    Tebentafusp-tebn With LDT in Metastatic UM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01057381, the US trial registry maintained by the National Library of Medicine. NCT01057381 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.